ion channels and g proteins discussion post

 

Ion Channels vs. G Proteins in Signal Transduction and Medication Targets

Ion Channels:

Ion channels are proteins that are in the cell membrane which facilitates the passage of ions in and out of the cell. They enable important physiologic processes such as signal transduction, they also react to particular  stimuli such as voltage changes or ligand binding. When these channels are activated, they open to allow ions such as sodium (Na+), potassium (K+), calcium (Ca2+), or chloride (Cl-) to pass through, altering the cell’s electrical state and initiating various cellular responses. Ion channels are also important targets for medications. For instance, calcium channel blockers, which are often used to treat high blood pressure, work by preventing calcium from entering heart and blood vessel muscle cells, leading to decreased heart contractility and blood vessel dilation (Benarroch, 2019).

G Proteins:

G proteins are proteins inside cells that act like switches, turning signals on or off. They help transmit messages from outside the cell, like hormones or neurotransmitters, to the inside. This process starts when these signals bind to special receptors on the cell surface, known as G protein-coupled receptors (GPCRs). When a signal binds to a GPCR, it activates the G protein by swapping a molecule called GDP for another called GTP on a part of the G protein called the α-subunit. When G proteins are activated, they interact with other proteins inside the cell, such as adenylate cyclase or phospholipase C. These proteins then produce molecules called secondary messengers, like cAMP or IP3, which carry the signal further inside the cell. This leads to various responses within the cell. Because GPCRs and G proteins are involved in many important body processes, they are key targets for many drugs. For example, medications like beta-blockers and angiotensin receptor blockers (ARBs) work by affecting these pathways to treat conditions like high blood pressure and heart disease (Skolnick & Volkow, 2020).

Differences in Medication Targeting

Target Mechanism:

Ion Channels: Medications targeting ion channels directly modulate the flow of ions across the membrane. For example, anesthetics such as lidocaine block sodium channels to prevent pain signals (Hille, 2018).

G Proteins: Drugs targeting G protein pathways typically act on the receptors that activate these proteins or on the signaling pathways they regulate. For example, antihistamines block histamine receptors, which are GPCRs, to reduce allergy symptoms (Skolnick & Volkow, 2020).

Speed of Action:

Ion Channels: The effects of ion channel-targeting drugs are often immediate, as they directly alter ion flow and membrane potential, which can quickly change cell activity (Benarroch, 2019).

G Proteins: The effects of drugs targeting G protein pathways can be slower because they often involve multiple steps, including the production of second messengers and the activation of downstream signaling pathways (Thal et al., 2018).

Specificity:

Ion Channels: Drugs targeting ion channels can be highly specific, affecting only one type of ion channel (e.g., calcium channel blockers), but there is a risk of off-target effects on similar ion channels in different tissues (Hille, 2018).

G Proteins: Since G protein pathways are involved in numerous physiological processes, drugs targeting these pathways can have widespread effects, sometimes leading to more side effects (Skolnick & Volkow, 2020).

Understanding Genetic Risk and Mental Illness: Having a relative with a mental illness, such as a grandmother, does increase your risk of developing a similar condition, but it does not guarantee that you will. Mental illnesses are complex and result from a combination of genetic, environmental, and lifestyle factors (Choi et al., 2020)

Genetic Factors: You share about 25% of your genes with your grandmother, which means you have inherited some genetic material from her. However, mental illnesses like depression, anxiety, bipolar disorder, and schizophrenia are influenced by multiple genes, each contributing a small amount to the overall risk (Levey et al., 2021). In addition to genetics, other factors such as your environment, life experiences, and personal behaviors play a significant role in whether you develop a mental illness (Gandal et al., 2018).

Environmental and Lifestyle Influences: Environmental factors, such as stress, trauma, and lifestyle choices (like diet, exercise, and substance use), interact with your genetic predisposition. Even if you have a higher genetic risk, maintaining a healthy lifestyle, seeking support when needed, and managing stress can reduce the likelihood of developing a mental illness (Gandal et al., 2018).

Protective Measures: Awareness of your family history allows you to take proactive steps in managing your mental health. Regular check-ins with a mental health professional, staying connected with a supportive community, and practicing self-care are all important strategies.

References

Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., … & CGTP Collaborators. (2021). The concise guide to pharmacology 2021/22: G protein-coupled receptors. British Journal of Pharmacology, 178(Supplement 1), S27-S156. https://doi.org/10.1111/bph.15434

Benarroch, E. E. (2019). Ion channels in neurological diseases: An update. Neurology, 92(6), 541-549. https://doi.org/10.1212/WNL.0000000000006910

Choi, K. W., Zheutlin, A. B., Karlson, R. A., Wang, M. J., Dunn, E. C., Stein, M. B., … & Smoller, J. W. (2020). Mapping the genetic architecture of major depression in the context of environmental risk: Leveraging both linkage-disequilibrium-dependent and -independent SNP heritability. American Journal of Psychiatry177(10), 917-927. https://doi.org/10.1176/appi.ajp.2020.19030310

Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C & Geschwind, D. H. (2018). Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science359(6376), 693-697. https://doi.org/10.1126/science.aad6469

Hille, B. (2018). Ion channels of excitable membranes (3rd ed.). Sinauer Associates.

Levey, D. F., Polimanti, R., Cheng, Z., Zhou, H., Nunez, Y. Z., Jain, S & Gelernter, J. (2021). Genetic associations with suicide attempt severity and genetic overlap with major depression. American Journal of Psychiatry178(9), 853-862. https://doi.org/10.1176/appi.ajp.2021.21030228

Skolnick, P., & Volkow, N. D. (2020). G protein-coupled receptors as targets for drug discovery in neuropsychiatric disorders. Neuropsychopharmacology, 45(1), 27-37. https://doi.org/10.1038/s41386-019-0464-6

Thal, D. M., Glukhova, A., Sexton, P. M., & Christopoulos, A. (2018). Structural insights into G-protein-coupled receptor allostery. Nature, 559(7712), 45-51. https://doi.org/10.1038/s41586-018-0245-2

Wray, N. R., Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A & Sullivan, P. F. (2018). Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nature Genetics50(5), 668-681. https://doi.org/10.1038/s41588-018-0090-3


Ion Channels and G Proteins 

This Discussion will allow you the opportunity to engage with your peers to explore the difference between ion channels and G proteins. You will be able to apply this understanding to a specific patient question. Additionally, please reply to your peers with additional information and sources to either support or challenge responses. 

Resources

 

Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources. 

WEEKLY RESOURCES

To prepare:

  • Review the Required Learning Resources.
  • Consider the difference between ion channels and G proteins.

By Day 3 of Week 1

Post a response answering the following:

  • Explain the difference between ion channels and G proteins as they relate to signal transduction and targets of medications.
  • How would you answer the following patient question:
    • My grandmother has a mental illness. I have the same genes as her. Will I also get the same mental illness?

Note: Your response needs to be supported and validated by three (3) scholarly peer-reviewed resources located outside of your course Learning Resources.

Upload a copy of your discussion writing to the draft Turnitin for plagiarism check.  Your faculty holds the academic freedom to not accept your work and grade at a zero if your work is not uploaded as a draft submission to Turnitin as instructed.

Read a selection of your colleagues’ posts.

By Day 6 of Week 1

You are required to participate in the Discussion on at least 3 different days (a different day for main post and each response). It is important to adhere to the weekly time frame to allow others ample time to respond to your posting.

Read a selection of your colleagues’ posts.  Respond to at least two of your colleagues on 2 different days by supporting or expanding on their explanation, as well as how they have described their response to the patient.

Peer responses should include at least two (2) supporting scholarly, peer-reviewed references outside of the provided Learning Resources. Your responses should also include additional resources to either support or refute the responses and should demonstrate critical thinking.

Note: Be sure you work to share additional perspectives on the details described by your colleague. Responses of “I agree” or “good point” will result in lower score grading.

Difference Between Ion Channels and G Proteins

Ion channels and G proteins both play critical roles in signal transduction but function differently. Ion channels are proteins embedded in the cell membrane that allow specific ions (like sodium, potassium, or calcium) to pass through the membrane in response to a signal, such as a neurotransmitter. This movement of ions changes the electrical charge of the cell, leading to rapid cellular responses. Ion channels are often targets for medications that require fast-acting effects, such as anesthetics or anti-seizure drugs (Hille, 2018).

G proteins, on the other hand, are involved in more complex signal transduction pathways. When a signaling molecule, such as a hormone, binds to a G protein-coupled receptor (GPCR) on the cell surface, it activates the G protein inside the cell. This activation triggers a cascade of intracellular events, affecting processes like metabolism, gene expression, and cell growth. G protein pathways are targets for drugs that modulate longer-term processes, such as beta-blockers for heart conditions or antipsychotics (Rosenbaum et al., 2020).

Targets of Medications

Both ion channels and G proteins are targets of various medications. For example, calcium channel blockers target ion channels to treat hypertension and heart disease (Smoller, 2019). In contrast, beta-blockers target GPCRs, which activate G proteins, to treat anxiety and hypertension.

Regarding your question, having the same genes as your grandmother does not guarantee you will develop the same mental illness. While genetics play a role in mental health, environmental factors, epigenetics, and gene expression also influence disease susceptibility (National Institute of Mental Health, 2020). A study published in the Journal of Psychiatric Research found that genetic factors contribute to the risk of developing mental illnesses, but environmental factors also play a crucial role (Smoller, 2019). Another study published in Nature Genetics highlighted the importance of gene-environment interactions in mental health (Sullivan et al., 2020). A review published in the Journal of Clinical Psychology emphasized the need to consider both genetic and environmental factors when assessing mental health risk.

In conclusion, Ion channels and G proteins differ in their roles within cellular communication, impacting how medications target these pathways. Ion channels work quickly by allowing ion flow, while G proteins initiate complex, longer-lasting responses. Regarding mental illness, while genetics contribute to risk, they are not the sole cause, and environmental factors play a significant role in determining whether one develops a condition. Understanding these differences can lead to better health outcomes through targeted treatment and informed healthcare choices.

 

 

References

Hille, B. (2018). Ion Channels of Excitable Membranes (3rd ed.). Sinauer Associates.

National Institute of Mental Health. (2020). Genetics and Mental Health. https://www.nimh.nih.gov/health/topics/genetics-and-mental-health/index.shtml

Rosenbaum, D. M., Rasmussen, S. G., & Kobilka, B. K. (2020). The structure and function of G-protein-coupled receptors. Nature, 459(7245), 356-363.

Smoller, J. W. (2019). The Genetics of Stress-Related Disorders: PTSD, Depression, and anxiety disorders. Neuropsychopharmacology, 44(1), 130-146.

Sullivan, P. F., Daly, M. J., & O’Donovan, M. (2020). Genetic architectures of psychiatric disorders: The emerging picture and its implications. Nature Reviews Genetics, 13(8), 537-551.

 

Reply from 

To understand how signals are transduced and how they target medications, we must understand what ion channels and G proteins are and how they function.

Ion channel receptors are receptors that open sodium or calcium channels through transducing electrical impulses into chemical signals allowing for some inorganic ions to pass and not others. Ion channels respond to a variety of stimuli that causes the channels to open including voltage across the membrane (voltage-gated channels), mechanical stress (mechanically gated channels, or binding of ligand (ligand-gated channels) (Alberts et al, 2008).

G protein or Guanosine triphosphate binding proteins are regulatory proteins that control a wide range of biological responses through biochemical reactions that cascades and modifies the function of target protein. The two general classes of G protein include heterotrimeric and monomeric G proteins. Heterotrimeric G proteins are composed of three subunits labeled A, B, and Y which creates a different reactive when each subunit is bonded downstream creating a variety of responses in the target cell. Monomeric G protein also known as small G Protein relay signals from activated cell surface receptors to intracellular targets. There are five subfamilies of monomeric G proteins that carry out different functions (Purves et al, 2001).

Ion channel receptors and g protein have been studied extensively and trialed in targets for creating medications for a desired outcome. Amlodipine besylate which is a calcium channel blocker was patented in 1982 and is one of the most widely used anti-hypertensive medications prescribed in the United States is an example of how ion channels may be manipulated for a desired effect. By stimulating the environment, cells are able to communicate with one another to create a desired effect in g proteins which is how clinic drugs are effective in such cases as quetiapine (Seroquel) or olanzapine (Zyprexa) (Raines et al, 2022).

To answer the question of whether a person would have the same mental illness as their grandmother, the answer is not necessarily. While a person may be predisposed to mental illness through genetics, epigenetics modifications during life experiences including chronic stress has been linked to modifications in genes that may lead to anxiety and/or depression. Aside from our genetics, biological pathways may become “activated or silenced” based upon our experiences and therefore will shape our mental health (Grezenko et al, 2023).

 

Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2008). Molecular Biology of the Cell. Garland Science Taylor & Francis Group. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK26910/

Grezenko, H., Ekhator, C., Nwabugwu, N., Ganga, H., Affaf, M., Abdelaziz, A., Rehman, A., Shehryar, A., Abbasai, F., Bellegarde, S., & Khaliq, A. (2023). Epigenetics in Neurological and Psychiatric Disorders: A Comprehensive Review of Current Understanding and Future Perspectives. Cureus, 15(8). DOI: 10.7759/cureus.43960

Purves, D., Augustine, G., Fitzpatrick, D., Hall, W., LaMantia, A., & White, L. (2001). Neuroscience, 2nd Edition. Sinauer Associates. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK10832/

Raines, R., McKnight, I., White, H., Legg, K., Lee, C., Li, W., Lee, P., & Shim, J. (2022). Drug-Targeted Genomes: Mutability of Ion Channels  and GPCRs. Biomedicines, 10(3), 594. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945769/

  • 2 Replies, 2 Unread

    2 Replies, 2 Unread

Aug 27, 2024 8:46pm

Reply from Chineze Christiana Chianakwana

Main discussion post:

Ion Channels and G proteins

Ion channels and G proteins are essential constituents of cellular signal transduction, acting in separate capacities and being the focus of different pharmaceutical interventions. Ion channels are membrane proteins that generate pores and facilitate the passage of certain ions (e.g., Na+, K+, Ca2+, and Cl-) across the cell membrane in reaction to stimuli, for example, a voltage change or ligand binding. Such ion transport can quickly modify the cell’s membrane potential and trigger biological reactions. Pharmacological agents such as anticonvulsants inhibit sodium channels to decrease neuronal excitability in epilepsy, and calcium channel blockers in the management of hypertension by vascular relaxation, primarily aim at ion channels (Hille, 2022).

G Proteins, also known as Guanine nucleotide-binding proteins, are intracellular proteins that function as molecular switches in routes of signal transmission. They transmit signals from active cell surface receptors, such as G-protein-coupled receptors (GPCRs), to different effectors within the cells, like enzymes and ion channels. Consequently, second messengers such as cAMP or IP3 can be generated, facilitating the transmission of the signal within the cell (Odoemelam et al., 2020). G protein pathway-targeting drugs like beta-blockers impede GPCR signaling for cardiovascular disease management, and antipsychotics, which regulate dopamine receptor activity for the management of mental illness.

Ion channels and G proteins are of great importance. They are essential constituents of biological signaling, although they operate through distinct mechanisms. For example, ion channels undergo opening or closing in reaction to specific external signals, such as variations in electrical potential or the interaction with a ligand. When in an open state, these membranes permit the passage of specified ions (such as Na+, K+, Ca2+, or Cl-) along their electrochemical gradient (McGivern & Ding, 2020). Conversely, G proteins are stimulated by G protein coupled receptors (GPCRs) upon binding of a ligand to the receptor. Upon activation, the G proteins engage with other intracellular proteins initiating a series of events that ultimately result in a biological response (Odoemelam et al., 2020).

Questions regarding the potential influence of family history on one’s health are reasonable. Although hereditary factors can predispose to some mental disorders, a positive family history of mental illness is not a guarantee that one will ultimately develop the same disorder.  Inheritance of certain genes does not guarantee the inheritance of all the same risk factors, as genetic expression might significantly differ among individuals (Sullivan & Geschwind, 2019).

Genetics is merely one parameter among several predisposing factors to mental disorders. Furthermore, environmental conditions, life events, lifestyle, and unique characteristics also exert substantial influence. Several mental health disorders are intricate and might arise from a confluence of genetic, environmental, and multifactorial influences (Goldin, 2023).

References

Goldin, D.S. (2023). Fast facts for psychopharmacology for nurse practitioners. Springer Publishing

Hille, B. (2022). Ionic channels in nerve membranes, 50 years on. Progress in Biophysics and Molecular Biology169–170, 12–20. https://doi.org/10.1016/j.pbiomolbio.2021.11.003Links to an external site.

McGivern, J. G., & Ding, M. (2020). Ion channels and relevant drug screening approaches. SLAS Discovery25(5), 413–419. https://doi.org/10.1177/2472555220921108

Odoemelam, C. S., Percival, B., Wallis, H., Chang, M.-W., Ahmad, Z., Scholey, D., Burton, E., Williams, I. H., Kamerlin, C. L., & Wilson, P. B. (2020). G-protein coupled receptors: Structure and function in Drug Discovery. RSC Advances10(60), 36337–36348. https://doi.org/10.1039/d0ra08003a

Rockman, H. A., & Lefkowitz, R. J. (2024). G protein–coupled receptors: From radioligand binding to cellular signaling. Journal of Clinical Investigation134(5). https://doi.org/10.1172/jci178109

Sullivan, P. F., & Geschwind, D. H. (2019). Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders. Cell177(1), 162–183. https://doi.org/10.1016/j.cell.2019.01.015Links to an external site.

 

Reply from Sabrina Quarmyne

According to the National Cancer Institute (2024), signal transduction is “the process by which a cell responds to substance outside the cell through signaling molecules found on the surface of and inside the cell. Most molecules bind to a specific protein receptor (signaling molecule) on or in a cell. Signal transduction is important for cells to grow and work normally.”

 

Ion channels and G proteins play a role in signal transductions but in different ways. Ion channels are gated permeable pathways that open for a limited time; an activator is needed to open the pathway. It allows specific ion (s) (sodium, potassium, calcium, and chloride) to flow across the membrane. The flow of ions changes the membrane potential, triggering cellular responses. One type of ion channel is the ligand-gated ion channel; the ionotropic receptors have a site where a neurotransmitter can bind, called the binding site. When the neurotransmitter binds (called the ligand), it causes the channel to open the receptor, and ions flow into the neuron (Alberts et al. 2019). “Ion channel signaling is a dynamic process that is essential for various physiological functions, including pain sensation, motor control, and fight or flight responses” (Dai, 2023). Some drugs/disorders that involve ion channels for treatment include cardiac arrhythmias, neuropathic pain, and muscle disorders (Dai, 2023).

 

G protein-coupled receptors (GPCRs) are proteins on the cell surface that conduct signals across the cell membrane. When a neurotransmitter binds to the receptor, it activates a G-protein, which can affect the opening of ion channels and activate signaling molecules, also known as second messengers, which initiate signaling cascades within the cell. The activation of the G protein exchanging GDP to GTP. G proteins regulate cellular responses through second messenger systems like cyclic AMP and phosphoinositide signaling pathways. G protein-coupled receptors (GPCRs) are slower-acting than the ion channels. GPCR activity changes lead to signaling pathway abnormalities affecting cardiovascular diseases, mental disorders, hormonal imbalances, and cancer. Drugs that target CPCRs include histamine receptor blockers, opioid agonists, beta-blockers, and angiotensin receptor blockers (Odoemelam et al., 2020)

 

Suppose a person were to ask if they will get the same mental illness as their grandmother because they have the same genes as her. It is reasonable for someone to have concerns if they will develop the same illness from a family member. Environmental variables (stress or trauma), family dynamics, and lifestyles can also play a factor in mental health illnesses as well as genetics. Although mental illness plays a role in predisposing others to mental health conditions, it is not entirely guaranteed that they may get the exact mental conditions as their grandmother (Whittle et al.2024).

 

References:

Alberts, B., Johnson, A., Lewis, J. (2019). Ion channels and the Electrical Properties of Membranes. Molecular Biology of the Cell, 4th edition. https://www.ncbi.nlm.nih.gov/books/NBK26910/Links to an external site.

Dai G. (2023). Signaling by Ion Channels: Pathways, Dynamics and Channelopathies. Missouri Medicine120(5), 367–373.

National Cancer Institute (2024). Signal Transduction Definitionhttps://www.cancer.gov/publications/dictionaries/cancer-terms/def/signal-transductionLinks to an external site.

Odoemelam, C., Percival, B., Wallis, H., Chang, M., Ahmad, Z., Scholey, D., Burton, E., Williams. (2020).  G protein-coupled receptors: structure and function in drug recovery. Royal Society of Chemistry, 10(4), 337-348

Whittle, S., Zhang, L., Rakesh,D. (2024). Environmental and neurodevelopmental contributors to youth mental illness. American College of Neuropsychopharmacology.  https://doi.org/10.1038/s41386-024-01926-yLinks to an external site.

 

  • 1 Reply, 1 Unread

    1 Reply, 1 Unread

Aug 27, 2024 4:14pmLast reply Aug 28, 2024 8:48pm

Reply from Odessa Fry

Discussion Post

Explain the Difference Ion Channel and G Protein Signal Transduction

There are different signal transduction cascades including G-protein-linked systems and ion-channel-linked systems.  Each starts with a diverse first messenger joining a unique receptor conducting activation of different downstream second, third, and so on chemical messengers (Stahl, 2021).  This allows a diverse biological collection of chemical messaging systems. G-protein-linked system and ion-channel-linked system are started by neurotransmitters. These systems prompt genes in the cell nucleus via phosphorylating a protein called CAMP response element binding protein CREB (Bondar, et al., 2020).  The G-protein-linked system works through a flow encompassing protein kinase A (Kostenis, et al., 2024). The ion-channel works across calcium with its capacity to stimulate and ability to activate a different kinase called calcium/calmodulin kinase (Maiorov, et al., 2024).

Regarding Mental Illness Transmission

Genetic evidence suggests that a sizable portion of genetic impacts exceed clinical diagnostic limitations of psychiatric disorders (Ashitha, 2023).  Neurotransmission triggers gene expression by a fast signal transduction that has a coded message that is passed along until the message is delivered to phosphoprotein or DNA.  Neurons alter their function by changing genes that are being turned on and off.  Molecular processes use neurotransmission to manage gene expression.  Genes only occupy a few percent of DNA, but these are essential for structure and regulation of whether a gene is conveyed or not.  The neuronal function deems gene expression is not only defined by numbers but by other circumstances as well.  These gene factors are also thought to underlie actions of psychopharmacological drugs and disorders in the central nervous system. Overall, it is possible for the gene to be transmitted to the granddaughter.

References

Ashitha, S., Ganesh, S., Purushottam, M., Viswanath, B., & Jain, S. (2023). T105. Genetic Influences of Neurodevelopmental Genes on Severe Mental Illnesses. European Neuropsychopharmacology, 75(Supplement 1), S219. https://doi.org/10.1016/j.euroneuro.2023.08.504

Bondar, A., Jang, W., Sviridova, E., & Lambert, N. A. (2020). Components of the Gs signaling cascade exhibit distinct changes in mobility and membrane domain localization upon β2‐adrenergic receptor activation. Traffic, 21(4), 324–332. https://doi.org/10.1111/tra.12724

Evi Kostenis, Lars Jürgenliemke, & Judith Alenfelder. (2024). G protein-mediated signal transduction: a molecular choreography of G protein activation after GTP binding. Signal Transduction and Targeted Therapy, 9(1), 1–3. https://doi.org/10.1038/s41392-024-01903-3Links to an external site.

Maiorov, S. A., Laryushkin, D. P., Kritskaya, K. A., Zinchenko, V. P., Gaidin, S. G., & Kosenkov, A. M. (2024). The Role of Ion Channels and Intracellular Signaling Cascades in the Inhibitory Action of WIN 55,212-2 upon Hyperexcitation. Brain Sciences (2076-3425), 14(7), 668. https://doi.org/10.3390/brainsci14070668Links to an external site.

Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press. Chapter 1, “Chemical Neurotransmission” (pp. 1–28)

  • 1 Reply, 1 Unread

    1 Reply, 1 Unread

Aug 26, 2024 6:44pmLast reply Aug 28, 2024 9:54pm

Reply from Akunna Onwuka

Ion channels are proteins in cell membranes that open channels for ions—charged particles such as sodium, potassium, calcium, and chloride—to flow through. These channels are critical in nerve and muscle cells for various biological functions.
Numerous physiological processes, such as controlling heart rate, contracting muscles, sending messages through nerves, and preserving homeostasis across cell membranes, depend on ion channels. Channelopathies, which include epilepsy, arrhythmias, and cystic fibrosis, are disorders caused by ion channel dysfunction. (Alexander et al., 2019).

Guanine nucleotide-binding proteins, or G proteins, are a family of proteins that play a pivotal role in cellular communication. They act as molecular switches in various signaling pathways, including hormones, neurotransmitters, and light and smell, effectively moving information from the cell’s exterior to its interior. ( Duncan et al., 2020).

The difference between ion channels and G proteins relates to signal transduction and medication targets.

Understanding the distinct functions that G proteins and ion channels play in signal transduction is crucial, especially in pharmacology.
Ion Channels: Membrane proteins called ion channels permit specific ions, such as Na, K, Ca, and Cl, to flow across the cell membrane. They aid in controlling cell electrical activity, especially in excitable tissues like neurons and muscle cells.  An ion channel can be immediately opened or closed to allow ions to enter or exit a cell when a signal, such as a neurotransmitter, attaches. This ion migration modifies the cell’s membrane potential, triggering other cellular reactions or resulting in an action potential (in neurons, for example).  Drugs targeting ion channels usually work by increasing or decreasing ion flow. For instance, sodium channels are blocked by local anesthetics such as lidocaine, which stops nerve impulses from spreading and lessens pain perception. Example: Calcium channel blockers, such as amlodipine, work by lowering the amount of calcium that enters the vascular smooth muscle, which causes vasodilation and the treatment of hypertension.  Ion channels mediate fast reactions because ions flow upon channel opening, and membrane potential changes nearly quickly.( Insel et al., 2019).
On the other hand, in G Proteins, G protein-coupled receptors (GPCRs) are surface-located intracellular signaling molecules that interact with G proteins. Various ligands, including neurotransmitters, hormones, and sensory signals, can trigger these receptors.  A GPCR is activated when a ligand attaches to it. This activation of the G protein sets off several downstream signaling pathways. This may result in changes in second messenger levels (cAMP, IP₃, etc.) or indirect ion channel activation. The exact G protein subtype (e.g., Gs, Gi, Gq) determines which pathways G proteins can activate or inhibit.  Many medications operate as agonists or antagonists, depending on the GPCR, to increase or decrease the receptor’s ability to interact with G proteins. For Example, Beta-blockers (such as propranolol) function as antagonists at beta-adrenergic GPCRs to lower blood pressure and heart rate. As an illustration, antipsychotic medications (such as risperidone) frequently modify neurotransmission by acting on dopamine receptors, which are GPCRs.  G protein signaling often takes longer than ion channel-mediated responses due to its many stages and secondary messenger synthesis.
Unlike the immediate, localized reactions observed with ion channels, the consequences can be more extensive and long-lasting.
Ion channels and G proteins are essential targets in pharmacology, and knowing their unique functions aids in forecasting how different drugs will affect the body.( Seyedabadi et al., 2019).

How I would answer the patient’s query regarding whether they will get the same mental illness because her grandmother has a mental illness and she has the same genes as her:

I will start by discussing with her/him that “Having a grandmother or other family member with a mental illness may somewhat raise her risk, but it does not ensure that she will experience the same illness. Combinations of hereditary and non-genetic variables, such as experiences, stress levels, lifestyle, and surroundings, can affect mental health. It does not follow that she will always have the same disease just because she has similar genes. She must prioritize her mental health by engaging in self-care, leading a healthy lifestyle, and, if necessary, obtaining professional assistance. I will also  discuss  the strategies on how she will   support her  mental health and watch for warning signals if  she is  worried.” This method encourages proactive mental health treatment while also offering comfort. (Duncan et al., 2020).

 

 

References

Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters,

J. A.Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J.

Sharman, J. L., Southan, C., Davies, J. A., Abbracchio, M. P., Alexander, W., Al-

hosaini, K., Bäck, M., Beaulieu, J., & Bernstein, K. E. (2019). THE CONCISE

GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors.

             British Journal of Pharmacology176(S1).

https://doi.org/10.1111/bph.14748Links to an external site.

Duncan, A. L., Song, W., & Sansom, M. S. P. (2020). Lipid-Dependent Regulation of

Ion Channels and G Protein–Coupled Receptors: Insights from Structures

and  Simulations. Annual Review of Pharmacology and Toxicology,

               60(1), 31– 50.

https://doi.org/10.1146/annurev-pharmtox-010919-023411Links to an external site..

 

Insel, P. A., Sriram, K., Gorr, M. W., Wiley, S. Z., Michkov, A., Salmerón, C., & Chinn,

A. M.  (2019). GPCRomics: An Approach to Discover GPCR Drug Targets.

               Trends in   Pharmacological Sciences40(6), 378–387.

https://doi.org/10.1016/j.tips.2019.04.001Links to an external site.

 

Seyedabadi, M., Ghahremani, M. H., & Albert, P. R. (2019). Biased signaling of G

protein-coupled receptors (GPCRs): Molecular determinants of

GPCR/transducer selectivity and therapeutic potential. Pharmacology &

             Therapeutics200, 148–178.

https://doi.org/10.1016/j.pharmthera.2019.05.006

 

Professor and class,

Ion channels and G proteins are both important in signal transduction. The former, are pore-forming proteins embedded in cell membranes that allow the selective passage of ions, such as sodium or chloride, across the membrane (Zheng & Trudeau, 2023, p. 37). This ion movement generates electrical signals in excitable cells like neurons and muscle cells. When a neurotransmitter binds to an ion channel, it can cause the channel to open or close, leading to an immediate change in the cell’s electrical state. As such, medications that target ion channels typically work by modulating this flow of ions, either enhancing or inhibiting the channel’s activity, and are often used to treat conditions like epilepsy, anxiety, and cardiac arrhythmias.

 

On their part, G proteins, are part of a larger signaling pathway that involves G protein-coupled receptors (GPCRs). When a signaling molecule, such as a hormone or neurotransmitter, binds to a GPCR, it activates the associated G protein, which then influences various intracellular signaling pathways (Yang, et al., 2021). This can lead to changes in enzyme activity, gene expression, or ion channel regulation, but these effects are generally slower and protracted compared to the direct actions of ion channels. According to Yang et al. (2021), medications targeting GPCRs and G proteins can modulate these signaling pathways, affecting a wide range of physiological processes. These drugs are commonly used in treating conditions like hypertension, depression, and allergies.

 

In response to the patient’s question, I would let her know that I understand her concerns, and while genetics do play a role in the risk for mental illness, having the same genes as your grandmother does not mean you will definitely develop the same condition. Mental illnesses are influenced by a combination of genetic, environmental, and lifestyle factors (Marees, et al., 2021). Hence, just because your grandmother had a mental illness does not mean you will have it too. It is important to focus on factors you can control, like maintaining a healthy lifestyle, managing stress, and seeking support if you ever need it.

 

References

Marees, A. T., Smit, D. J., Abdellaoui, A., Nivard, M. G., van den Brink, W., Denys, D., . . . Derks, E. M. (2021). Genetic correlates of socio-economic status influence the pattern of shared heritability across mental health traits. Nature Human Behaviour, 5, 1065-1073. https://doi.org/10.1038/s41562-021-01053-4Links to an external site.

Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., . . . Xie, L. (2021). G protein-coupled receptors: Structure- and function-based drug discovery. Signal Transduction and Targeted Therapy, 6(7), e574. https://doi.org/10.1038/s41392-020-00435-wLinks to an external site.

Zheng, J., & Trudeau, M. C. (2023). Textbook of ion channels. Boca Raton, FL: CRC Press.